Use of testosterone in the prevention of anemia in patients on hemodialysis
Antos, M.; Jeren, B.; Prejac, M.
Vojnosanitetski Pregled 32(2): 174-176
1975
ISSN/ISBN: 0042-8450 PMID: 1136272 Document Number: 87991
Document emailed within 1 workday
Related Documents
Ball, J.H.; Lowrie, E.G.; Hampers, C.L.; Merrill, J.P. 1975: Testosterone therapy in hemodialysis patients Clinical Nephrology 4(3): 91-98Heinrichs, H.R.; Milde, K.; Junkers, K.; Heinze, V.; Burmeister, P. 1973: Plasma testosterone level of male patients during chronic hemodialysis Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 734-738
Duffy, B.S.; Tauber, J.; Chrysant, S.G.; Zerefos, N.S.; Gandhi, V.; Case, L.F.; Kaplan, E.; Lavender, A.R. 1972: Factors influencing hematocrit response to testosterone in patients on chronic hemodialysis Proceedings of the Clinical Dialysis and Transplant Forum 2: 120-122
Jacquot, C.; Berthelot, J.M.; Chiappini-Judith, D.; Ferragu-Haguet, M.; Lefebvre, A.; Masselot, J.P.; Moynot, A.; Frydman, M.O.; Peterlongo, F. 1990: Treatment of anemia in chronic hemodialysis patients with recombinant human erythropoietin: long-term results in 15 patients Nephrologie 11(1): 11-16
Di Iorio, B.; Guastaferro, P.; Gironda, A.; Marano, V.; Morrongiello, L.; Cillo, N.; Zito, B.; Nigro, F.; Frieri, A.; Rubino, R.; Bellizzi, V. 2002: Can anemia be corrected in hemodialysis patients with thalassaemia minor? Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 19(5): 552-559
Hu, J.P.; Cheng, X.; Xu, X.F.; Yu, G.J.; Luo, F.; Zhang, G.S.; Yang, N.; Shen, P.; Yan, X.Y. 2016: Reactivity of patients with maintenance hemodialysis to erythropoietin in the treatment of renal anemia Journal of Biological Regulators and Homeostatic Agents 30(2): 535-540
Krairittichai, U.; Supaporn, T.; Aimpun, P.; Wangsiripaisan, A.; Chaiprasert, A.; Sakulsaengprapha, A.; Chittinandana, A.; Thanachartwet, W.; Palasawatdhi, V.; Srangsomwong, S. 2006: Anemia and survival in Thai hemodialysis patients: evidence from national registry data Journal of the Medical Association of Thailand 89 Suppl. 2: S242-S247
Boratyńska, M.; Szewczyk, Z.; Szepietowski, T.; Czyz, W.; Cybulski, K.; Bogucki, J.; Szczepański, J. 1990: Human recombinant erythropoietin in the treatment of anemia in patients on long-term hemodialysis Przeglad Lekarski 47(11): 741-745
Hou, C.C.; Wu, S.C.; Wu, S.C.; Chen, T.W.; Yang, W.C.; Ng, Y.Y. 1999: Is serum transferrin receptor a sensitive marker of iron repletion in patients with iron-deficiency anemia and hemodialysis patients? Zhonghua Yi Xue Za Zhi 62(4): 189-194
Ohkubo, M.; Ishimitsu, T.; Kawaguchi, T.; Abe, M.; Yagi, S. 1993: Efficacy and safety of long-term erythropoietin therapy in chronic hemodialysis patients with renal anemia Nihon Jinzo Gakkai Shi 35(2): 171-177
Miura, Y. 1978: Serum transferrin levels in chronic renal failure. II. the relationship between anemia and nutrition in regular hemodialysis patients Nihon Jinzo Gakkai Shi 20(3): 243-253
Agroyannis, B.; Koutsicos, D.; Tzanatou-Exarchou, H.; Varsou-Papadimitriou, E.; Kapetanaki, A.; Yatzidis, H. 1991: Combined recombinant human erythropoietin-blood letting strategy for treating anemia and iron overload in hemodialysis patients International Journal of Artificial Organs 14(7): 403-406
Thanakitcharu, P.; Siriwiwatanakul, N. 2007: Hemoglobin response and influence on left ventricular hypertrophy after 24-week treatment of a biosimilar epoetin-alfa in hemodialysis patients with anemia Journal of the Medical Association of Thailand 90(12): 2574-2586
Zueva, N.A.; Lipskaia, O.E.; Efimov, A.S. 2002: Effect of eprex in therapy of anemia of nephrogenic genesis in patients with chronic renal failure concurrent with diabetic glomerulosclerosis before hemodialysis Likars'ka Sprava 8: 129-132
Tsai, J.C.; Lai, Y.H.; Tsai, Z.Y.; Chien, L.J.; Tsai, J.H. 1991: Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum Gaoxiong Yi Xue Ke Xue Za Zhi 7(3): 126-135
Djordjević, V.; Kostić, S.; Avramović, M.; Radivojević, J.; Paunović, G.; Stefanović, V. 1996: Prevention of hepatitis C infection in hemodialysis patients International Journal of Artificial Organs 19(4): 258-259
Recchia, G.; Gulino, S.; Dean, P.; Prati, G.; Firpo, M.; Galvani, E.; Muolo, A.; Ancona, G. 1984: Sideropenic anemia in patients under periodic hemodialysis treatment: efficacy and safety of oral iron treatment La Clinica Terapeutica 108(5): 397-404
Hansz, J.; Furmaniuk, J. 1975: Testosterone treatment in aplastic anemia Polski Tygodnik Lekarski 30(31-32): 1323-1325
Andò, S.; Giacchetto, C.; Colpi, G.M.; Beraldi, E.; Panno, M.L.; Sposato, G. 1985: Testosterone precursors in spermatic venous blood of normal men and varicocele patients. A study of delta 4 pathway of testosterone biosynthesis Acta Endocrinologica 108(2): 277-283
Boczkowski, K.; Ozieblo, L. 1976: Testosterone concentrations and testosterone transporting protein binding capacity in blood plasma samples from patients with gonadal dysgenesis Ginekologia Polska 47(2): 191-194